Nantes University Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Nantes University Hospital appears in 122 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials122

Recruiting shown19

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of ObesityNCT07378072 · lead sponsor · 2026-06-17

Dental Management of Patients With HIV in Pays de la LoireNCT07552038 · lead sponsor · 2026-05-02

Nantes Bariatric Surgery CohortNCT06625762 · lead sponsor · 2026-03-23

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart DiseaseNCT07257289 · lead sponsor · 2026-02-03

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NENNCT06735560 · lead sponsor · 2025-11-04

Pressure-Volume Loop Assessment in Valvular Heart DiseaseNCT07112391 · lead sponsor · 2025-09-04

Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With ObesityNCT07027033 · lead sponsor · 2025-07-15

Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer PatientsNCT06481813 · lead sponsor · 2024-12-10

Echocardiography in Nursing HomeNCT06445231 · lead sponsor · 2024-10-02

Study of OCT Peripapillary Angiography in Patients With Advanced GlaucomaNCT06274593 · lead sponsor · 2024-04-27

Biocollection on Peripheral InflammationNCT05934474 · lead sponsor · 2024-03-19

Evaluation of Possible Postoperative Complications After Nissen Sleeve Gastrectomy. French Multicenter StudyNCT06271317 · lead sponsor · 2024-03-01

Premorbid Personality Profile of Patients With Cognitive and Behavioral DisordersNCT06059313 · lead sponsor · 2023-12-14

Common and Specific Information From Neuroimaging and SmartphoneNCT05482906 · lead sponsor · 2023-04-03

Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With AsthmaNCT05525169 · lead sponsor · 2022-11-15

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple SclerosisNCT04873492 · lead sponsor · 2022-01-24

Predictive Signature of Benralizumab ResponseNCT04565483 · lead sponsor · 2021-10-11

Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple SclerosisNCT02912897 · lead sponsor · 2021-01-26

Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)NCT04180085 · lead sponsor · 2020-02-06

Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated ObesityNCT07423481 · lead sponsor · 2026-10-01

NOT_YET_RECRUITING

PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple SclerosisNCT07647952 · lead sponsor · 2026-06-30

NOT_YET_RECRUITING

Implementation Trial In patieNts With rEnal failuRe and diAbetes for Major Adverse reNal and Cardiovascular EventsNCT07634718 · lead sponsor · 2026-06-01

NOT_YET_RECRUITING

Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional AidNCT05607849 · lead sponsor · 2025-04-16

Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living With Diabetes Using Continuous Glucose Monitoring ( GAP OUEST )NCT06185491 · lead sponsor · 2024-06-24

ACTIVE_NOT_RECRUITING

Intubation of Obese Patients in the Operating Room With or Without Face Mask VentilationNCT05930678 · lead sponsor · 2023-09-12

Peer Support Impact on Therapeutic Adherence in Patients With Multiple SclerosisNCT05519553 · lead sponsor · 2023-05-17

ACTIVE_NOT_RECRUITING

Autobiographical SpecificityNCT05642351 · lead sponsor · 2023-02-03

Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery.NCT05283213 · lead sponsor · 2022-11-22

Observational Single-center Study of the Relationship Between Arterial Hypertension and Hypervolemia Defined by Self-measurement of Impedancemetry in Kidney Transplant Patients With Transplantation Less Than 6 Months OldNCT05039788 · lead sponsor · 2021-10-14

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable DeviceNCT04969848 · lead sponsor · 2021-08-18

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes MellitusNCT04232293 · lead sponsor · 2021-06-25

Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple SclerosisNCT04777539 · lead sponsor · 2021-06-14

Autobiographical MemoryNCT04584138 · lead sponsor · 2021-04-15

Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic SteatosisNCT04270656 · lead sponsor · 2021-02-05

Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin TherapyNCT04572009 · lead sponsor · 2021-01-12

Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's DiseaseNCT04652843 · lead sponsor · 2020-12-17

Study on the Prevalence of Hepatitis C In a psychiatRic PopulationNCT04600479 · lead sponsor · 2020-11-26

PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release TacrolimusNCT04496401 · lead sponsor · 2020-09-28

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate PneumoniaNCT04453384 · lead sponsor · 2020-09-01

"COVID-19 and Diabetes Outcomes"NCT04324736 · lead sponsor · 2020-03-10

Genetic Study of Familial Forms of Non-atopic AsthmaNCT02911220 · lead sponsor · 2020-02-26

Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )NCT04108728 · lead sponsor · 2019-11-19

MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtibNCT03865511 · lead sponsor · 2019-04-09

Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler (MICRODOPPLER PLACENTA)NCT03860103 · lead sponsor · 2019-04-01

Assessing the Expression and the Activity of Rac1 Protein in the Airway Smooth Muscle of Asthmatic PatientNCT03325088 · lead sponsor · 2019-03-05

Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 DiabetesNCT03344692 · lead sponsor · 2019-02-12

Cost-utility Analysis of Maintenance rTMS for Treatment-resistant DepressionNCT03701724 · lead sponsor · 2018-11-05

Pharmacokinetics of Levosimendan in Pediatric Intensive Care UnitsNCT03681379 · lead sponsor · 2018-09-23

Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective StudyNCT03572712 · lead sponsor · 2018-08-14

Exploration of the Enteric Nervous System in Alzheimer DiseaseNCT03472183 · lead sponsor · 2018-04-26

Identification of a Biomarker Predictive of Evolution of Parkinson DiseaseNCT03230526 · lead sponsor · 2018-04-16

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIVNCT03451032 · lead sponsor · 2018-03-15

Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis PatientsNCT03369171 · lead sponsor · 2018-01-23

Enhanced FoCUS in Patients With Shortness of BreathNCT05403619 · lead sponsor · 2018-01-01

Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real LifeNCT03020264 · lead sponsor · 2017-11-28

Adapted Physical Activity StudyNCT03337412 · lead sponsor · 2017-11-13

QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-PatientNCT03195452 · lead sponsor · 2017-11-08

Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's DiseaseNCT03487380 · lead sponsor · 2017-09-04

Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology OutpatientsNCT03306784 · lead sponsor · 2017-07-03

Preoxygenation Optimisation in Obese PatientsNCT03106441 · lead sponsor · 2017-06-21

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Nantes University Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo3

alirocumab1

belatacept Injection1

benralizumab Prefilled Syringe1

citrulline1

lactose1

metformin1

mirabegron1

placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials alirocumab RxCUI 1659152 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial belatacept Injection RxCUI 1804971 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial benralizumab Prefilled Syringe RxCUI 1989103 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial citrulline RxCUI 2567 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial lactose RxCUI 6211 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial mirabegron RxCUI 1300786 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial omeprazole RxCUI 7646 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pravastatin RxCUI 42463 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial rabeprazole RxCUI 114979 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor102

collaborator20

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.